Synergy/Antagonism visualisation and calculation using Bliss Independence and Highest Single Agent (HSA)
-
Updated
May 31, 2026 - R
Synergy/Antagonism visualisation and calculation using Bliss Independence and Highest Single Agent (HSA)
ML-driven platform for Glioblastoma drug recommendation using GDSC data. Features multi-model prediction (RF, XGBoost, NN, SVM, KNN), molecular similarity analysis (Tanimoto, MCS, GCN), pathway enrichment, drug interaction checking, and combination therapy optimization with interactive dashboard.
Add a description, image, and links to the combination-therapy topic page so that developers can more easily learn about it.
To associate your repository with the combination-therapy topic, visit your repo's landing page and select "manage topics."